AU3735793A - Retroviral protease inhibitors - Google Patents
Retroviral protease inhibitorsInfo
- Publication number
- AU3735793A AU3735793A AU37357/93A AU3735793A AU3735793A AU 3735793 A AU3735793 A AU 3735793A AU 37357/93 A AU37357/93 A AU 37357/93A AU 3735793 A AU3735793 A AU 3735793A AU 3735793 A AU3735793 A AU 3735793A
- Authority
- AU
- Australia
- Prior art keywords
- protease inhibitors
- retroviral protease
- retroviral
- inhibitors
- protease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
- 230000001177 retroviral effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US842295 | 1986-03-26 | ||
| US84229592A | 1992-02-26 | 1992-02-26 | |
| US84229992A | 1992-02-26 | 1992-02-26 | |
| US842299 | 1992-02-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3735793A true AU3735793A (en) | 1993-09-13 |
Family
ID=27126334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU37357/93A Abandoned AU3735793A (en) | 1992-02-26 | 1993-02-26 | Retroviral protease inhibitors |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0628035A4 (en) |
| JP (1) | JPH07504417A (en) |
| AU (1) | AU3735793A (en) |
| WO (1) | WO1993017003A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA49803C2 (en) * | 1994-06-03 | 2002-10-15 | Дж.Д. Сьорль Енд Ко | METHOD FOR TREATMENT OF RETROVIRAL INFECTIONS |
| WO1998038167A1 (en) * | 1997-02-26 | 1998-09-03 | Pfizer Inc. | Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| EP1498417A1 (en) * | 2000-02-04 | 2005-01-19 | Pfizer Products Inc. | Heterocyclic amide derivatives |
| AP2002002595A0 (en) * | 2000-02-04 | 2002-09-30 | Pfizer Prod Inc | Heterocyclic amide derivatives. |
| DE60124080T2 (en) | 2000-03-23 | 2007-03-01 | Elan Pharmaceuticals, Inc., San Francisco | COMPOUNDS AND METHOD FOR THE TREATMENT OF ALZHEIMER'S DISEASE |
| MXPA02012560A (en) | 2000-06-30 | 2003-05-14 | Elan Pharm Inc | Compounds to treat alzheimer s disease. |
| US6846813B2 (en) | 2000-06-30 | 2005-01-25 | Pharmacia & Upjohn Company | Compounds to treat alzheimer's disease |
| EP1666452A2 (en) | 2000-06-30 | 2006-06-07 | Elan Pharmaceuticals, Inc. | Compounds to treat Alzheimer's disease |
| PE20020276A1 (en) | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | SUBSTITUTE AMINE COMPOUNDS AS ß-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER |
| US6982264B2 (en) | 2001-06-27 | 2006-01-03 | Elan Pharmaceuticals, Inc. | Substituted alcohols useful in treatment of Alzheimer's disease |
| IL309732A (en) | 2021-07-09 | 2024-02-01 | Aligos Therapeutics Inc | Anti-viral compounds |
| WO2023043816A1 (en) | 2021-09-17 | 2023-03-23 | Aligos Therapeutics, Inc. | Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3997551A (en) * | 1970-12-30 | 1976-12-14 | Argus Chemical Corporation | 3-Salicylamido-s-triazoles |
| US4038406A (en) * | 1972-09-26 | 1977-07-26 | Bayer Aktiengesellschaft | 1,2,4-triazole antimycotic compositions and use thereof |
| US4505919A (en) * | 1982-10-09 | 1985-03-19 | Pfizer Inc. | Antifungal S-arylmethyl- and S-heterocyclylmethyl ethers of 2-aryl-3-mercapto-1-(1H-1,2,4-triazol-1-yl) propan-2-ols |
-
1993
- 1993-02-26 AU AU37357/93A patent/AU3735793A/en not_active Abandoned
- 1993-02-26 WO PCT/US1993/001785 patent/WO1993017003A1/en not_active Ceased
- 1993-02-26 EP EP93906262A patent/EP0628035A4/en not_active Withdrawn
- 1993-02-26 JP JP5515105A patent/JPH07504417A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPH07504417A (en) | 1995-05-18 |
| WO1993017003A1 (en) | 1993-09-02 |
| EP0628035A4 (en) | 1995-03-29 |
| EP0628035A1 (en) | 1994-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3566089A (en) | Retroviral protease inhibitors | |
| AU5533094A (en) | Enzyme inhibitors | |
| KR100190517B1 (en) | Hiv protease inhibitors | |
| HU9302080D0 (en) | Amine-diole protease inhibitors | |
| ZA915269B (en) | Retroviral protease inhibitors | |
| AU5208193A (en) | Guanidinyl-substituted heterocyclic thrombin inhibitors | |
| HU9601508D0 (en) | Dp-iv-serine protease inhibitors | |
| IL102534A0 (en) | Retroviral protease inhibitors | |
| AU9122391A (en) | Hiv protease inhibitors | |
| AU5069993A (en) | Retroviral protease inhibitors | |
| AU4678489A (en) | Retroviral protease inhibitors | |
| AU7963394A (en) | Mercaptosulfide metalloproteinase inhibitors | |
| AU8320691A (en) | Inhibitors of retroviral proteases | |
| AU8994191A (en) | Retroviral protease inhibitors derived from 3-chloro-2- chloromethyl-1-propene | |
| AU3735793A (en) | Retroviral protease inhibitors | |
| AU7518694A (en) | Retroviral protease inhibitors and combinations thereof | |
| AUPM982594A0 (en) | HIV protease inhibitors | |
| AU6828894A (en) | Hiv protease inhibitors | |
| AU7132391A (en) | Hiv protease inhibitors | |
| EP0566237A3 (en) | Retroviral protease inhibitors. | |
| IL105450A0 (en) | Hydroxy-carbamate retroviral protease inhibitors | |
| HK1014508A (en) | Dp-iv-serine protease inhibitors | |
| AU1739792A (en) | Novel thrombin inhibitors | |
| HK1008334A (en) | Hiv protease inhibitors | |
| ZA925360B (en) | Retroviral protease inhibitors. |